AUSTIN, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that the Company will report its financial results for the three months and year ended December 31, 2023, on Thursday, March 28, 2024. Management will also host a conference call at an updated time of 8:30 am ET to discuss financial results and provide a corporate update. Details for the call are as follows:
Conference Call & Webcast Details: | ||
Date: | Thursday, March 28, 2024 | |
Time: | 8:30 am ET (NEW TIME) | |
Toll Free: | 877-407-4018 | |